Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica

Virology

Volumn 246, Issue 2, 1998, Pages 317-328

  Roehrig, John T ^a   Bolin, Richard A ^a   Kelly, Robert G ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANTIBODY PRODUCTION; ARTICLE; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TICK BORNE ENCEPHALITIS; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

ACARI; DENGUE VIRUS; DENGUE VIRUS TYPE 2; FLAVIVIRUS; MURINAE; RNA VIRUSES; TICK-BORNE ENCEPHALITIS VIRUS;

EID: 0032486594     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9200     Document Type: Article

References (31)

1. Aaskov J. G., Geysen H. M., Mason T.J. Serologically defined linear epitopes in the envelope protein of dengue-2 (Jamaica strain 1409). Arch. Virol. 105:1989;209-221.
2. Gentry M. K., Henchal E. A., McCown J. M., Brandt W. E., Dalrymple J. M. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am. J. Trop. Med. Hyg. 31:1982;548-555.
3. Gollins S. W., Porterfield J. S. A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature (London). 321:1986;244-246.
4. Guirakhoo F., Bolin R. A., Roehrig J. T. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of the E glycoprotein. Virology. 191:1992;921-931.
5. Guirakhoo F., Heinz F. X., Kunz C. Epitope model of tick-borne encephalitis virus envelope glycoprotein E: Analysis of structural properties, role of carbohydrate, and conformational changes occurring at acidic pH. Virology. 169:1989;90-99.
6. Guirakhoo F., Hunt A. R., Lewis J. G., Roehrig J. T. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology. 194:1993;219-223.
7. Heinz F. X., Roehrig J. T. Flaviviruses. Immunochemistry of Viruses. II. The Basis for Serodiagnosis and Vaccines. 1990;Elsevier, Amsterdam. p. 289-305.
8. Henchal E. A., McCown J. M., Burke D. S., Seguin M. C., Brandt W. E. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am. J. Trop. Med. Hyg. 34:1985;162-169.
9. Hiramatsu K., Tadano M., Lai C.-J. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: Monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology. 224:1996;437-445.
10. Innis B. L., Thirawuth V., Hemachudha C. Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. Am. J. Trop. Med. Hyg. 40:1989;676-687.
11. Jainmin Z., Linn M. L., Bulich R., Gentry M. K., Aaskov J.G. Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies. Arch. Virol. 140:1995;899-913.
12. Johnson A. J., Guirakhoo F., Roehrig J. T. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology. 203:1994;241-249.
13. Kaufman B. M., Summers P. L., Dubois D. R., Eckels K. H. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36:1987;427-434.
14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 277:1970;680-685.
15. Lin B., Parrish C. R., Murray J. M., Wright P. J. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology. 202:1994;885-890.
16. Mandl C. W., Guirakhoo F. G., Holzmann H., Heinz F. X., Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 63:1989;564-571.
17. Mason P. W., Dalrymple J. M., Gentry M. K., McCown J. M., Hoke C. H., Burke D. S., Fournier M. J., Mason T. L. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70:1989;2037-2049.
18. Megret F., Hugnot J. P., Falconar A., Gentry M. K., Morens D. M., Murray J. M., Schlesinger J. J., Wright P. J., Young P., Van Regenmortel M. H. V., Deubel V. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology. 187:1992;480-491.
19. Monath T. P., Wands J. R., Hill L. J., Gentry M. K., Gubler D. J. Multisite monoclonal immunoassay for dengue viruses: Detection of viraemic human sera and interference by heterologous antibody. J. Gen. Virol. 67:1986;639-650.
20. Obijeski J. F., Marchenko A. T., Bishop D. H. L., Cann B. W., Murphy F. A. Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses. J. Gen. Virol. 22:1974;21-22.
21. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature. 375:1995;291-298.
22. Roehrig J. T. Immunochemistry of dengue viruses. Gubler D. J., Kuno G. K. Dengue and Dengue Hemorraghic Fever. 1997;199-219 CAB Int. New York.
23. Roehrig J. T., Corser J. A., Schlesinger M. J. Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology. 101:1980;41-49.
24. Roehrig J. T., Day J. W., Kinney R. M. Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology. 118:1982;269-278.
25. Roehrig J. T., Mathews J. H., Trent D. W. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology. 128:1983;118-126.
26. Roehrig J. T., Mathews J. H. The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology. 142:1985;347-356.
27. Roehrig J. T., Johnson A. J., Hunt A. R., Bolin R. A., Chu M. C. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology. 177:1990;668-675.
28. Roehrig J. T., Risi P. A., Brubaker J. R., Hunt A. R., Beaty B. J., Trent D. W., Mathews J. H. T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology. 198:1994;31-38.
29. Ross A. H., Herlyn D., Koprowski H. Purification of monoclonal antibodies from ascites using Abx liquid chromatography column. J. Immunol. Methods. 102:1987;227-231.
30. Trirawatanapong T., Chandran B., Putnak R., Padmanabhan R. Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody. Gene. 116:1992;139-150.
31. Winkler G., Heinz F. X., Kunz C. Characterization of a disulphide bridge-stabilized antigenic domain of tick-borne encephalitis virus structural glycoprotein. J. Gen. Virol. 68:1987;2239-2244.